ACHIEVE LIFE SCIENCES, INC. Logo

ACHIEVE LIFE SCIENCES, INC.

A late-stage pharmaceutical company developing a treatment for nicotine dependence.

ACHV | US

Overview

Corporate Details

ISIN(s):
US0044685008
LEI:
Country:
United States of America
Address:
22722 29TH DR. SE, 98021 SEATTLE

Description

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company dedicated to addressing the global nicotine dependence epidemic. The company's primary focus is the development and commercialization of its lead product candidate, cytisinicline, for smoking cessation. Following the successful completion of two Phase 3 studies, the company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), which has been accepted for review. If approved, cytisinicline has the potential to become the first new FDA-approved treatment option for nicotine dependence in the United States in nearly two decades.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-05-07 02:15 English ZIP 5.3 KB
2024-05-02 18:05 English ZIP 7.8 KB
2024-05-02 14:36 English ZIP 58.2 KB
2024-04-26 18:34
S-3
English ZIP 88.4 KB
2024-04-26 18:07
ARS
English ZIP 868.2 KB
2024-04-26 18:05
DEF 14A
English ZIP 2.0 MB
2024-04-23 18:39
4
English ZIP 7.8 KB
2024-04-23 18:35
4
English ZIP 7.7 KB
2024-04-23 18:31
4
English ZIP 7.8 KB
2024-04-23 18:26
4
English ZIP 7.6 KB
2024-03-28 17:47
S-8
English ZIP 51.5 KB
2024-03-28 17:14
10-K
English ZIP 2.6 MB
2024-03-28 17:06
8-K
English ZIP 143.8 KB
2024-03-06 17:49
4
English ZIP 7.8 KB
2024-03-06 17:43
4
English ZIP 7.9 KB

Automate Your Workflow. Get a real-time feed of all ACHIEVE LIFE SCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACHIEVE LIFE SCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACHIEVE LIFE SCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.